arthritis psoriatica
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: active disease defined as not in MDA - 30 patients inactive disease defined as in MDA - 30 patients healthy controls - 20 subjects
Exclusion criteria
Exclusion criteria: other disease that linfluence movement such CVA, prostethic limb etc in patients and sport trauma in healthy controls
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| As described above we aim to develop digital biomarkers of disease activity which could include data from the accelerometers of the telephone, metadata of the keystroke path possibly combined with camera data. This will be then compared to clinical disease activity and self-reported symptoms. Clinical disease activity is measured by validated measures of disease activity: Minimal disease Activity * MDA - [20], Psoriatic Arthritis Disease Activity Score (PASDAS)[22], and Disease Activity Psoriatic Arthritis) (DAPSA) | — |
Countries
Netherlands
Outcome results
None listed